−3.5919 USD
−436.37 M USD
11.58 M USD
139.21 M
About Revolution Medicines, Inc.
Sector
CEO
Mark A. Goldsmith
Headquarters
Redwood City
Website
Founded
2004
FIGI
BBG01K4M90R2
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
Displays a symbol's price movements over previous years to identify recurring trends.